Agilon Health Inc. (AGL) Misses Q4 EPS by 17c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
agilon health Inc (AGL) PT Lowered to $7.50 at Truist Securities
February 29, 2024 5:50 AM ESTTruist Securities analyst Jailendra Singh lowered the price target on agilon health Inc (NYSE: AGL) to $7.50 (from $10.00) while maintaining a Hold rating.
The analyst comments "We are updating our AGL model to reflect the company's updated cost trend expectations and 2024 outlook,... More



